Cure My Disease

Don't miss your cure!

 Log in / Sign up

New kidney drug shows promise in early safety trial

NCT ID NCT01279538

Completed Disease control Sponsor: Astellas Pharma Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a single dose of a new drug called ASKP1240 in 50 people who just received a kidney transplant. The goal was to see how the drug moves through the body, how safe it is, and how well it works. Participants were randomly assigned to get the drug or a placebo, and researchers monitored their health closely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY TRANSPLANTATION

Contacts and locations

Locations

  • Baylor University Medical Center

    Dallas, Texas, 75246, United States

  • Beth Israel Deaconess Medical Center, The Transplant Institute

    Boston, Massachusetts, 02215, United States

  • California Institute of Renal Research

    San Diego, California, 92123, United States

  • California Pacific Medical Center

    San Francisco, California, 94115, United States

  • Central Pennsylvania Transplant Associates

    Harrisburg, Pennsylvania, 17104, United States

  • Christ Hospital

    Cincinnati, Ohio, 45219, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Loyola University Medical Center

    Maywood, Illinois, 60153, United States

  • Methodist University Hospital

    Memphis, Tennessee, 38104, United States

  • St. Barnabas Medical Center

    Livingston, New Jersey, 07039, United States

  • Stanford University Medical Center

    Palo Alto, California, 94304, United States

  • The Methodist Hospital

    Houston, Texas, 77030, United States

  • UCSF Medical Center

    San Francisco, California, 94143, United States

  • University of Cincinnati - University Internal Medicine Associates

    Cincinnati, Ohio, 45219, United States

  • University of Colorado Denver

    Aurora, Colorado, 80045, United States

  • University of Illinois Medical Center

    Chicago, Illinois, 60612, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

  • University of Utah Hospital

    Salt Lake City, Utah, 84132, United States

  • University of Wisconsin

    Madison, Wisconsin, 53705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.